作者: Betsy J. Lahue , Eva Baginska , Sophia S. Li , Monika Parisi
DOI: 10.1017/S0266462315000197
关键词: Health technology 、 Family medicine 、 Cervical cancer 、 Pathology 、 Mass screening 、 MEDLINE 、 Metric (unit) 、 Nice 、 Cervical screening 、 Medicine 、 Alternative medicine
摘要: Objectives: The aim of this study was to conduct a review health technology assessments (HTAs) in cervical cancer screening highlight the most common metrics HTA agencies use evaluate and recommend technologies. Methods: Center for Reviews Dissemination (CRD), MedLine, national agency databases were searched using keywords (“cervical screening” OR “cervical cancer” screening”) “HTA” from January 2000 October 2014. Non-English language reports without English summaries, non-HTA reports, HTAs unrelated intervention sufficient summaries available online excluded. We used various National Institute Health Care Excellence (NICE) methods extract key assessment criteria determine whether change practice recommended. Results: One hundred ten unique identified; forty-four seventeen countries met inclusion criteria. All evaluated technologies among women. Ten identified either as an or comparator. outcome metric diagnostic accuracy, followed by economic effectiveness. Additional such adjunct testing, intervals, age-specific testing commonly evaluated. Nearly one-third (fifteen forty-four) recommended practice. Conclusions: This highlights popular screening. Clinical effectiveness have been consistently assessed HTAs, while became increasingly prevalent after 2007. Moreover, we observed increase optimized recommendations